← Evidence map

ReviewDrug safety1999

A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.

G HajakPubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

1999

…

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

this papercites it

A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience. | OpenQuestion